Pneumococcal Vaccines Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032

  • Report ID: ME_0064192
  • Format: Electronic (PDF)
  • Publish Type:
  • Number of Pages: 250
Home Healthcare pneumococcal vaccines market....
  • Single User $3500
  • Multi User $4500
  • Enterprise User $5500

Market Snapshot

CAGR:5.93
2023
2032

Source: Market Expertz

RND-Favicon
Study Period 2019-2032
Base Year 2023
Forcast Year 2023-2032
CAGR 5.93
Healthcare-companies
Healthcare-Snapshot

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf
Download Sample Pdf

Report Overview

The global Pneumococcal Vaccines market is valued at million US$ in 2018 and will reach million US$ by the end of 2026, growing at a CAGR of during 2019-2026. The objectives of this study are to define, segment, and project the size of the Pneumococcal Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of Pneumococcal Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pneumococcal Vaccines in these regions.
This research report categorizes the global Pneumococcal Vaccines market by top players/brands, region, type and end user. This report also studies the global Pneumococcal Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac

Market size by Product
PPSV 23
PCV 7/13
PCV 10
Market size by End User
For Infants
For Children (2-10)
For Person (10-64)
For The Old (≥65)

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Pneumococcal Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2026.
To understand the structure of Pneumococcal Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pneumococcal Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pneumococcal Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pneumococcal Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pneumococcal Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Pneumococcal Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pneumococcal Vaccines Market Size Growth Rate by Product
1.4.2 PPSV 23
1.4.3 PCV 7/13
1.4.4 PCV 10
1.5 Market by End User
1.5.1 Global Pneumococcal Vaccines Market Size Growth Rate by End User
1.5.2 For Infants
1.5.3 For Children (2-10)
1.5.4 For Person (10-64)
1.5.5 For The Old (?65)
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Pneumococcal Vaccines Market Size
2.1.1 Global Pneumococcal Vaccines Revenue 2014-2026
2.1.2 Global Pneumococcal Vaccines Sales 2014-2026
2.2 Pneumococcal Vaccines Growth Rate by Regions
2.2.1 Global Pneumococcal Vaccines Sales by Regions
2.2.2 Global Pneumococcal Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Pneumococcal Vaccines Sales by Manufacturers
3.1.1 Pneumococcal Vaccines Sales by Manufacturers
3.1.2 Pneumococcal Vaccines Sales Market Share by Manufacturers
3.1.3 Global Pneumococcal Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Pneumococcal Vaccines Revenue by Manufacturers
3.2.1 Pneumococcal Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Pneumococcal Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Pneumococcal Vaccines Price by Manufacturers
3.4 Pneumococcal Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Pneumococcal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pneumococcal Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Pneumococcal Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Pneumococcal Vaccines Sales by Product
4.2 Global Pneumococcal Vaccines Revenue by Product
4.3 Pneumococcal Vaccines Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Pneumococcal Vaccines Breakdown Data by End User

6 North America
6.1 North America Pneumococcal Vaccines by Countries
6.1.1 North America Pneumococcal Vaccines Sales by Countries
6.1.2 North America Pneumococcal Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pneumococcal Vaccines by Product
6.3 North America Pneumococcal Vaccines by End User

7 Europe
7.1 Europe Pneumococcal Vaccines by Countries
7.1.1 Europe Pneumococcal Vaccines Sales by Countries
7.1.2 Europe Pneumococcal Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pneumococcal Vaccines by Product
7.3 Europe Pneumococcal Vaccines by End User

8 Asia Pacific
8.1 Asia Pacific Pneumococcal Vaccines by Countries
8.1.1 Asia Pacific Pneumococcal Vaccines Sales by Countries
8.1.2 Asia Pacific Pneumococcal Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pneumococcal Vaccines by Product
8.3 Asia Pacific Pneumococcal Vaccines by End User

9 Central & South America
9.1 Central & South America Pneumococcal Vaccines by Countries
9.1.1 Central & South America Pneumococcal Vaccines Sales by Countries
9.1.2 Central & South America Pneumococcal Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pneumococcal Vaccines by Product
9.3 Central & South America Pneumococcal Vaccines by End User

10 Middle East and Africa
10.1 Middle East and Africa Pneumococcal Vaccines by Countries
10.1.1 Middle East and Africa Pneumococcal Vaccines Sales by Countries
10.1.2 Middle East and Africa Pneumococcal Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pneumococcal Vaccines by Product
10.3 Middle East and Africa Pneumococcal Vaccines by End User

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Pneumococcal Vaccines Products Offered
11.1.5 Pfizer Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Company Business Overview
11.2.3 Sanofi Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sanofi Pneumococcal Vaccines Products Offered
11.2.5 Sanofi Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 Company Business Overview
11.3.3 GSK Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 GSK Pneumococcal Vaccines Products Offered
11.3.5 GSK Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Company Business Overview
11.4.3 Merck Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Merck Pneumococcal Vaccines Products Offered
11.4.5 Merck Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Company Business Overview
11.5.3 Eli Lilly Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Eli Lilly Pneumococcal Vaccines Products Offered
11.5.5 Eli Lilly Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 Company Business Overview
11.6.3 AstraZeneca Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 AstraZeneca Pneumococcal Vaccines Products Offered
11.6.5 AstraZeneca Recent Development
11.7 Abera
11.7.1 Abera Company Details
11.7.2 Company Business Overview
11.7.3 Abera Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Abera Pneumococcal Vaccines Products Offered
11.7.5 Abera Recent Development
11.8 S K Chemicals
11.8.1 S K Chemicals Company Details
11.8.2 Company Business Overview
11.8.3 S K Chemicals Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 S K Chemicals Pneumococcal Vaccines Products Offered
11.8.5 S K Chemicals Recent Development
11.9 Beijing Minhai Biotechnology
11.9.1 Beijing Minhai Biotechnology Company Details
11.9.2 Company Business Overview
11.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Beijing Minhai Biotechnology Pneumococcal Vaccines Products Offered
11.9.5 Beijing Minhai Biotechnology Recent Development
11.10 Baxter
11.10.1 Baxter Company Details
11.10.2 Company Business Overview
11.10.3 Baxter Pneumococcal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Baxter Pneumococcal Vaccines Products Offered
11.10.5 Baxter Recent Development
11.11 Biken
11.12 Celgene Corporation
11.13 Panacea Biotec
11.14 Serum Institute of India
11.15 Genentech
11.16 Genocea Biosciences
11.17 ImmunoBiology
11.18 Lupin
11.19 Nuron Biotech
11.20 Biogen
11.21 Valneva Austria
11.22 Sinovac

12 Future Forecast
12.1 Pneumococcal Vaccines Market Forecast by Regions
12.1.1 Global Pneumococcal Vaccines Sales Forecast by Regions 2019-2026
12.1.2 Global Pneumococcal Vaccines Revenue Forecast by Regions 2019-2026
12.2 Pneumococcal Vaccines Market Forecast by Product
12.2.1 Global Pneumococcal Vaccines Sales Forecast by Product 2019-2026
12.2.2 Global Pneumococcal Vaccines Revenue Forecast by Product 2019-2026
12.3 Pneumococcal Vaccines Market Forecast by End User
12.4 North America Pneumococcal Vaccines Forecast
12.5 Europe Pneumococcal Vaccines Forecast
12.6 Asia Pacific Pneumococcal Vaccines Forecast
12.7 Central & South America Pneumococcal Vaccines Forecast
12.8 Middle East and Africa Pneumococcal Vaccines Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pneumococcal Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer


List of Tables and Figures

Figure Pneumococcal Vaccines Product Picture
Table Pneumococcal Vaccines Market Segments
Table Key Manufacturers Pneumococcal Vaccines Covered
Table Global Pneumococcal Vaccines Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Pneumococcal Vaccines Sales Market Share by Product 2014-2025
Figure PPSV 23 Product Picture
Table Major Manufacturers of PPSV 23
Figure PCV 7/13 Product Picture
Table Major Manufacturers of PCV 7/13
Figure PCV 10 Product Picture
Table Major Manufacturers of PCV 10
Table Global Pneumococcal Vaccines Market Size Growth Rate by End User 2019-2025 (K Units)
Figure For Infants
Figure For Children (2-10)
Figure For Person (10-64)
Figure For The Old (?65)
Figure Pneumococcal Vaccines Report Years Considered
Figure Global Pneumococcal Vaccines Market Size 2014-2025 (Million US$)
Figure Global Pneumococcal Vaccines Sales 2014-2025 (K Units)
Table Global Pneumococcal Vaccines Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Pneumococcal Vaccines Sales by Regions 2014-2019 (K Units)
Table Global Pneumococcal Vaccines Sales Market Share by Regions 2014-2019
Figure Global Pneumococcal Vaccines Sales Market Share by Regions 2014-2019
Figure 2018 Global Pneumococcal Vaccines Sales Market Share by Regions
Table Global Pneumococcal Vaccines Revenue by Regions 2014-2019 (Million US$)
Table Global Pneumococcal Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Pneumococcal Vaccines Revenue Market Share by Regions 2014-2019
Figure 2018 Global Pneumococcal Vaccines Revenue Market Share by Regions
Table Global Pneumococcal Vaccines Sales by Manufacturers (2014-2019) (K Units)
Table Global Pneumococcal Vaccines Sales Share by Manufacturers (2014-2019)
Figure Global Pneumococcal Vaccines Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Pneumococcal Vaccines Revenue by Manufacturers (2014-2019) (Million USD)
Table Pneumococcal Vaccines Revenue Share by Manufacturers (2014-2019)
Figure Pneumococcal Vaccines Value Share by Manufacturers in 2018
Table Key Manufacturers Pneumococcal Vaccines Price (2014-2019) (USD/Unit)
Table Pneumococcal Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Pneumococcal Vaccines Product Type
Table Date of International Manufacturers Enter into Pneumococcal Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Pneumococcal Vaccines Sales by Product (2014-2019) (K Units)
Table Global Pneumococcal Vaccines Sales Share by Product (2014-2019)
Figure Global Pneumococcal Vaccines Sales Market Share by Product (2014-2019)
Figure Global Pneumococcal Vaccines Sales Market Share by Product in 2018
Table Global Pneumococcal Vaccines Revenue by Product (2014-2019) (Million US$)
Table Global Pneumococcal Vaccines Revenue Share by Product (2014-2019)
Figure Global Pneumococcal Vaccines Revenue Market Share by Product (2014-2019)
Figure Global Pneumococcal Vaccines Revenue Market Share by Product in 2018
Table Pneumococcal Vaccines Price by Product 2014-2019 (USD/Unit)
Table Global Pneumococcal Vaccines Sales by End User (2014-2019) (K Units)
Table Global Pneumococcal Vaccines Sales Share by End User (2014-2019)
Figure Global Sales Pneumococcal Vaccines Market Share by End User (2014-2019)
Figure Global Sales Pneumococcal Vaccines Market Share by End User in 2018
Figure North America Pneumococcal Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure North America Pneumococcal Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table North America Pneumococcal Vaccines Sales by Countries (2014-2019) (K Units)
Table North America Pneumococcal Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 North America Pneumococcal Vaccines Sales Market Share by Countries
Table North America Pneumococcal Vaccines Revenue by Countries (2014-2019) (Million US$)
Table North America Pneumococcal Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Pneumococcal Vaccines Revenue Market Share by Countries
Figure United States Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure United States Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Canada Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table North America Pneumococcal Vaccines Sales by Product (2014-2019) (K Units)
Table North America Pneumococcal Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 North America Pneumococcal Vaccines Market Share by Product
Table North America Pneumococcal Vaccines Sales by End User (2014-2019) (K Units)
Table North America Pneumococcal Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 North America Pneumococcal Vaccines Market Share by End User
Figure Europe Pneumococcal Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Europe Pneumococcal Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Pneumococcal Vaccines Sales by Countries (2014-2019) (K Units)
Table Europe Pneumococcal Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Pneumococcal Vaccines Sales Market Share by Countries
Table Europe Pneumococcal Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Europe Pneumococcal Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Pneumococcal Vaccines Revenue Market Share by Countries
Figure Germany Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Germany Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure France Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure France Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure UK Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Italy Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Russia Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Pneumococcal Vaccines Sales by Product (2014-2019) (K Units)
Table Europe Pneumococcal Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Europe Pneumococcal Vaccines Market Share by Product
Table Europe Pneumococcal Vaccines Sales by End User (2014-2019) (K Units)
Table Europe Pneumococcal Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Europe Pneumococcal Vaccines Market Share by End User
Figure Asia Pacific Pneumococcal Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Pneumococcal Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Pneumococcal Vaccines Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Pneumococcal Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pneumococcal Vaccines Sales Market Share by Countries
Table Asia Pacific Pneumococcal Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Pneumococcal Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pneumococcal Vaccines Revenue Market Share by Countries
Figure China Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure China Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Japan Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Korea Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure India Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure India Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Australia Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Pneumococcal Vaccines Sales by Product (2014-2019) (K Units)
Table Asia Pacific Pneumococcal Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Pneumococcal Vaccines Market Share by Product
Table Asia Pacific Pneumococcal Vaccines Sales by End User (2014-2019) (K Units)
Table Asia Pacific Pneumococcal Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Pneumococcal Vaccines Market Share by End User
Figure Central & South America Pneumococcal Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Pneumococcal Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Pneumococcal Vaccines Sales by Countries (2014-2019) (K Units)
Table Central & South America Pneumococcal Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pneumococcal Vaccines Sales Market Share by Countries
Table Central & South America Pneumococcal Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Pneumococcal Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pneumococcal Vaccines Revenue Market Share by Countries
Figure Brazil Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Pneumococcal Vaccines Sales by Product (2014-2019) (K Units)
Table Central & South America Pneumococcal Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Pneumococcal Vaccines Market Share by Product
Table Central & South America Pneumococcal Vaccines Sales by End User (2014-2019) (K Units)
Table Central & South America Pneumococcal Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Pneumococcal Vaccines Market Share by End User
Figure Middle East and Africa Pneumococcal Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Pneumococcal Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Pneumococcal Vaccines Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Pneumococcal Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pneumococcal Vaccines Sales Market Share by Countries
Table Middle East and Africa Pneumococcal Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Pneumococcal Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pneumococcal Vaccines Revenue Market Share by Countries
Figure GCC Countries Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Pneumococcal Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Pneumococcal Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Pneumococcal Vaccines Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Pneumococcal Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Pneumococcal Vaccines Market Share by Product
Table Middle East and Africa Pneumococcal Vaccines Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Pneumococcal Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Pneumococcal Vaccines Market Share by End User
Table Pfizer Company Details
Table Pfizer Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development

Table Sanofi Company Details
Table Sanofi Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development

Table GSK Company Details
Table GSK Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Recent Development

Table Merck Company Details
Table Merck Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development

Table Eli Lilly Company Details
Table Eli Lilly Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development

Table AstraZeneca Company Details
Table AstraZeneca Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development

Table Abera Company Details
Table Abera Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abera Recent Development

Table S K Chemicals Company Details
Table S K Chemicals Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table S K Chemicals Recent Development

Table Beijing Minhai Biotechnology Company Details
Table Beijing Minhai Biotechnology Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Beijing Minhai Biotechnology Recent Development

Table Baxter Company Details
Table Baxter Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Baxter Recent Development

Table Biken Company Details
Table Celgene Corporation Company Details
Table Panacea Biotec Company Details
Table Serum Institute of India Company Details
Table Genentech Company Details
Table Genocea Biosciences Company Details
Table ImmunoBiology Company Details
Table Lupin Company Details
Table Nuron Biotech Company Details
Table Biogen Company Details
Table Valneva Austria Company Details
Table Sinovac Company Details
Table Global Pneumococcal Vaccines Sales Forecast by Regions 2019-2025 (K Units)
Table Global Pneumococcal Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Global Pneumococcal Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Pneumococcal Vaccines Revenue Market Share Forecast by Regions 2019-2025
Table Global Pneumococcal Vaccines Sales Forecast by Product 2019-2025 (K Units)
Table Global Pneumococcal Vaccines Sales Market Share Forecast by Product 2019-2025
Table Global Pneumococcal Vaccines Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Pneumococcal Vaccines Revenue Market Share Forecast by Product 2019-2025
Table Global Pneumococcal Vaccines Sales Forecast by End User 2019-2025 (K Units)
Table Global Pneumococcal Vaccines Sales Market Share Forecast by End User 2019-2025
Figure North America Pneumococcal Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Pneumococcal Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Pneumococcal Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Pneumococcal Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Pneumococcal Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Pneumococcal Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Pneumococcal Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Pneumococcal Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Pneumococcal Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Pneumococcal Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Pneumococcal Vaccines Value Chain
Table Pneumococcal Vaccines Customers List
Table Pneumococcal Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Personalized Business Report Tailored to Your Requirements

  • Our expert analysts collaborate directly with you to comprehend your specific needs.
  • Get data on regions, segments, competitors, and vendors of your choice.
  • Information is presented in alignment with your exact preferences and formatting.
Free Sample Report

"Find new revenue generation opportunities"